MEDICAL CAPITAL MANAGEMENT INC
SB-2/A, EX-1.04, 2001-01-18
SHORT-TERM BUSINESS CREDIT INSTITUTIONS
Previous: MEDICAL CAPITAL MANAGEMENT INC, SB-2/A, EX-1.03, 2001-01-18
Next: MEDICAL CAPITAL MANAGEMENT INC, SB-2/A, EX-8.01, 2001-01-18



                                                                    Exhibit 1.04

                                 AMENDMENT NO. 1
                                       TO
                             BROKER-DEALER AGREEMENT

     THIS  AMENDMENT  NO. 1 TO  BROKER-DEALER  AGREEMENT  (the  "Amendment")  is
entered  into  and  made as of the 17th day of  January,  2001,  by and  between
Medical Capital  Management,  Inc., a Delaware  corporation (the "Issuer"),  and
Metropolitan    Investment    Securities,    a   Washington   corporation   (the
"Broker-Dealer" and together with the Issuer, the "Parties").

                                    RECITALS

     WHEREAS,  the  Issuer  and the  Broker-Dealer  entered  into  that  certain
Broker-Dealer  Agreement (the "Agreement"),  between the Parties, as of the 19th
day of October,  2000, for the purpose of engaging  Broker-Dealer to offer, sell
and  distribute  certain  secured  notes  (the  "Notes")  of  the  Issuer  on  a
best-efforts basis (the "Offering").

     WHEREAS,  in  accordance  with the  rules of the  National  Association  of
Securities  Dealers,  the compensation  payable to the  Broker-Dealer  under the
Agreement for sales of Notes in the Offering must be amended as hereinafter  set
forth.

     NOW,   THEREFORE,   in   consideration   of  their  mutual   covenants  and
undertakings, the Parties do hereby agree as follows:

     The following Section 1.1 shall be added to the Agreement:

     "SECTION 1.1.  LIMITATIONS  ON SALES.  Notwithstanding  anything  contained
herein to the  contrary,  the total  amount of Class C Notes that may be sold in
the Offering by all brokers  combined will not exceed  $20,000,000  in aggregate
principal  amount and the total  amount of Class D Notes that may be sold in the
Offering  by all  brokers  combined  will not exceed  $10,000,000  in  aggregate
principal amount."

     Section 9 of the Agreement is deleted in its entirety and replaced with the
following:

     "SECTION 9.  COMPENSATION.  Issuer  shall  compensate  Broker-Dealer  in an
amount equal to 3.5% to 9.5% of the  principal  amount of the Notes sold by that
Broker-Dealer,  as set forth on  Exhibit A. Said  compensation  shall be due and
payable  within  ten days of  receipt  of good funds by the Issuer as payment in
full of the purchase price of the Notes sold by the Broker-Dealer."

     Exhibit A to the  Agreement  shall be deleted in its  entirety and replaced
with Exhibit A attached to this Amendment.
<PAGE>
     IN WITNESS  WHEREOF,  the parties hereto have executed this Amendment as of
the date first above written.

                                    MEDICAL CAPITAL MANAGEMENT, INC.

                                    By: /s/ Joseph J. Lampariello
                                        ----------------------------------------
                                        Joseph J. Lampariello,
                                        Chief Operating Officer


                                    BROKER DEALER


                                    METROPOLITAN INVESTMENT SECURITIES

                                    By: /s/ Anthony Pizelo
                                        ----------------------------------------
                                        Anthony Pizelo, General Manager/V.P.
<PAGE>
                                    EXHIBIT A


                           TO: BROKER-DEALER AGREEMENT

         This Agreement provides for the following commission rate structure
based on the class of Note sold.

         CLASS A  - Commission paid at the rate of   3.5%

         CLASS B  - Commission paid at the rate of   6.5%

         CLASS C  - Commission paid at the rate of   8.5%

         CLASS D  - Commission paid at the rate of   9.5%





© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission